Literature DB >> 19887889

Group psychotherapy of dysfunctional fear of progression in patients with chronic arthritis or cancer.

Peter Herschbach1, Petra Berg, Sabine Waadt, Gabriele Duran, Ursula Engst-Hastreiter, Gerhard Henrich, Katrin Book, Andreas Dinkel.   

Abstract

BACKGROUND: This study investigated the effectiveness of brief psychotherapeutic group interventions in reducing dysfunctional fear of disease progression (FoP). The interventions comprised either cognitive-behavioral group therapy or supportive-experiential group therapy. We tested whether these generic interventions would prove effective in different illness types.
METHODS: Chronic arthritis in- patients (n = 174) and cancer in-patients (n = 174), respectively, were randomized to receive one of the two interventions. The patients provided data before intervention, at discharge, and at 3 and 12 months of follow-up. FoP was the primary outcome, secondary outcomes were anxiety, depression and quality of life. A treatment-as-usual control group provided data on the primary outcome.
RESULTS: Patients with chronic arthritis indicated higher levels of FoP than cancer patients. The results revealed that, compared with no specialized intervention, both group therapies were effective in reducing dysfunctional FoP, but only among cancer patients. The effect sizes were 0.54 (cognitive-behavioral therapy) and 0.50 (supportive experiential therapy). The interventions were not differently effective in reducing the secondary outcomes.
CONCLUSIONS: Dysfunctional FoP can be effectively targeted with brief group interventions. Psychotherapeutic interventions for reducing FoP should focus on specific illness characteristics.

Entities:  

Mesh:

Year:  2009        PMID: 19887889     DOI: 10.1159/000254903

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  27 in total

1.  A Systematic Review of Interventions for Health Anxiety Presentations Across Diverse Chronic Illnesses.

Authors:  Danielle Petricone-Westwood; Georden Jones; Brittany Mutsaers; Caroline Séguin Leclair; Christina Tomei; Geneviève Trudel; Andreas Dinkel; Sophie Lebel
Journal:  Int J Behav Med       Date:  2019-02

2.  Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT.

Authors:  S Sarkar; A Scherwath; L Schirmer; F Schulz-Kindermann; K Neumann; M Kruse; A Dinkel; S Kunze; F Balck; N Kröger; U Koch; A Mehnert
Journal:  Bone Marrow Transplant       Date:  2014-07-07       Impact factor: 5.483

3.  Addressing fear of cancer recurrence among women with cancer: a feasibility and preliminary outcome study.

Authors:  Sophie Lebel; Christine Maheu; Monique Lefebvre; Scott Secord; Christine Courbasson; Mina Singh; Lynne Jolicoeur; Aronela Benea; Cheryl Harris; Michael Fung Kee Fung; Zeev Rosberger; Pamela Catton
Journal:  J Cancer Surviv       Date:  2014-04-23       Impact factor: 4.442

4.  Cost-effectiveness of cognitive-behavioral group therapy for dysfunctional fear of progression in cancer patients.

Authors:  C Sabariego; M Brach; P Herschbach; P Berg; G Stucki
Journal:  Eur J Health Econ       Date:  2010-08-06

5.  Psychological intervention (ConquerFear) for treating fear of cancer recurrence: mediators and moderators of treatment efficacy.

Authors:  Louise Sharpe; J Turner; J E Fardell; B Thewes; A B Smith; J Gilchrist; J Beith; A Girgis; S Tesson; S Day; K Grunewald; P Butow
Journal:  J Cancer Surviv       Date:  2019-07-25       Impact factor: 4.442

6.  [Beneficial outcomes of an interdisciplinary psychoeducative group intervention for patients with malignant gliomas and their relatives].

Authors:  Annemarie U Schratter-Sehn; Christine Schipke; Claudia Steffal; Alexandra Schratter
Journal:  Wien Med Wochenschr       Date:  2011-01

7.  Cognitive-behavioural therapy targeting fear of progression in an interdisciplinary care program: a case study in systemic sclerosis.

Authors:  Linda Kwakkenbos; Linda M Willems; Frank H J van den Hoogen; Wim G J M van Lankveld; Hanneke Beenackers; Toon F van Helmond; Eni S Becker; Cornelia H M van den Ende
Journal:  J Clin Psychol Med Settings       Date:  2014-12

8.  Fear of progression in patients 6 months after cancer rehabilitation-a- validation study of the fear of progression questionnaire FoP-Q-12.

Authors:  Andreas Hinz; Anja Mehnert; Jochen Ernst; Peter Herschbach; Thomas Schulte
Journal:  Support Care Cancer       Date:  2014-11-21       Impact factor: 3.603

9.  Evaluation of two group therapies to reduce fear of progression in cancer patients.

Authors:  Peter Herschbach; Katrin Book; Andreas Dinkel; Petra Berg; Sabine Waadt; Gabriele Duran; Ursula Engst-Hastreiter; Gerhard Henrich
Journal:  Support Care Cancer       Date:  2009-10-29       Impact factor: 3.603

10.  Does fear of cancer recurrence predict cancer survivors' health care use?

Authors:  Sophie Lebel; Christina Tomei; Andrea Feldstain; Sara Beattie; Megan McCallum
Journal:  Support Care Cancer       Date:  2012-12-27       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.